Home › Multiple Myeloma › Texas › Lubbock
Multiple Myeloma clinical trials in Lubbock, TX
3 studies for Multiple Myeloma are looking for participants at sites in and around Lubbock (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
RecruitingPhase 3
- Joe Arrington Cancer Research Treatment Center, Lubbock
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 3
- Joe Arrington Cancer Research Treatment Center, Lubbock
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
RecruitingPhase 3
- Joe Arrington Cancer Research and Treatment Center, Lubbock
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO26 studies
- Columbus, OH24 studies
- Baldwin Park, CA23 studies
- St. Louis, MO23 studies
- Rochester, MN23 studies
- Washington, DC22 studies
Other studies in Lubbock
- Crohn's Disease10 studies
- Ulcerative Colitis9 studies
- Breast Cancer6 studies
- Non-Small Cell Lung Cancer4 studies
- Psoriatic Arthritis3 studies
- Inflammatory Bowel Disease3 studies
- Burkitt Lymphoma3 studies
- Obesity3 studies
- Overweight3 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.